BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 15328327)

  • 1. Cost-lowering strategies used by medicare beneficiaries who exceed drug benefit caps and have a gap in drug coverage.
    Tseng CW; Brook RH; Keeler E; Steers WN; Mangione CM
    JAMA; 2004 Aug; 292(8):952-60. PubMed ID: 15328327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of an annual dollar limit or "cap" on prescription drug benefits for Medicare patients.
    Tseng CW; Brook RH; Keeler E; Mangione CM
    JAMA; 2003 Jul; 290(2):222-7. PubMed ID: 12851277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elderly patients' knowledge of drug benefit caps and communication with providers about exceeding caps.
    Tseng CW; Dudley RA; Brook RH; Keeler E; Hixon AL; Manlucu LR; Mangione CM
    J Am Geriatr Soc; 2009 May; 57(5):848-54. PubMed ID: 19484840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Falling into the doughnut hole: drug spending among beneficiaries with end-stage renal disease under Medicare Part D plans.
    Patel UD; Davis MM
    J Am Soc Nephrol; 2006 Sep; 17(9):2546-53. PubMed ID: 16855016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PDP or MA-PD? Medicare part D enrollment decisions in CMS Region 25.
    Cline RR; Worley MM; Schondelmeyer SW; Schommer JC; Larson TA; Uden DL; Hadsall RS
    Res Social Adm Pharm; 2010 Jun; 6(2):130-42. PubMed ID: 20511112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medicare drug beneficiaries and cost-lowering strategies.
    Bjarnason NH; Kampmann JP
    JAMA; 2005 Feb; 293(5):552-3; author reply 553. PubMed ID: 15687306
    [No Abstract]   [Full Text] [Related]  

  • 7. Medicare beneficiaries' knowledge of Part D prescription drug program benefits and responses to drug costs.
    Hsu J; Fung V; Price M; Huang J; Brand R; Hui R; Fireman B; Newhouse JP
    JAMA; 2008 Apr; 299(16):1929-36. PubMed ID: 18430912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medicare beneficiaries' management of capped prescription benefits.
    Cox ER; Jernigan C; Coons SJ; Draugalis JL
    Med Care; 2001 Mar; 39(3):296-301. PubMed ID: 11242323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gap in drug coverage often causes lapses in adherence to drug regimen, study shows.
    Levenson D
    Rep Med Guidel Outcomes Res; 2004 Sep; 15(18):9-10, 12. PubMed ID: 15452947
    [No Abstract]   [Full Text] [Related]  

  • 10. Prescription drug spending for Medicare+Choice beneficiaries in the last year of life.
    Fahlman C; Lynn J; Doberman D; Gabel J; Finch M
    J Palliat Med; 2006 Aug; 9(4):884-93. PubMed ID: 16910803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unintended consequences of caps on Medicare drug benefits.
    Hsu J; Price M; Huang J; Brand R; Fung V; Hui R; Fireman B; Newhouse JP; Selby JV
    N Engl J Med; 2006 Jun; 354(22):2349-59. PubMed ID: 16738271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Will the Medicare prescription drug benefit eliminate cost barriers for older adults with diabetes mellitus?
    Tjia J; Schwartz JS
    J Am Geriatr Soc; 2006 Apr; 54(4):606-12. PubMed ID: 16686870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of cost sharing on prescription drugs used by Medicare beneficiaries.
    Goedken AM; Urmie JM; Farris KB; Doucette WR
    Res Social Adm Pharm; 2010 Jun; 6(2):100-9. PubMed ID: 20511109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unfilled prescriptions of medicare beneficiaries: prevalence, reasons, and types of medicines prescribed.
    Kennedy J; Tuleu I; Mackay K
    J Manag Care Pharm; 2008; 14(6):553-60. PubMed ID: 18693779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compliance among pharmacies in California with a prescription-drug discount program for Medicare beneficiaries.
    Lewis JH; Schonlau M; Muñoz JA; Asch SM; Rosen MR; Yang H; Escarce JJ
    N Engl J Med; 2002 Mar; 346(11):830-5. PubMed ID: 11893795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medicare Prescription Drug Plan Enrollees Report Less Positive Experiences Than Their Medicare Advantage Counterparts.
    Elliott MN; Landon BE; Zaslavsky AM; Edwards C; Orr N; Beckett MK; Mallett J; Cleary PD
    Health Aff (Millwood); 2016 Mar; 35(3):456-63. PubMed ID: 26953300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Problems due to medication costs among VA and non-VA patients with chronic illnesses.
    Piette JD; Heisler M
    Am J Manag Care; 2004 Nov; 10(11 Pt 2):861-8. PubMed ID: 15609740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Employer drug benefit plans and spending on prescription drugs.
    Joyce GF; Escarce JJ; Solomon MD; Goldman DP
    JAMA; 2002 Oct; 288(14):1733-9. PubMed ID: 12365957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The new Medicare Part D prescription drug benefit: an estimation of its effect on prescription drug costs in a Medicare population with atrial fibrillation.
    Evans-Molina C; Regan S; Henault LE; Hylek EM; Schwartz GR
    J Am Geriatr Soc; 2007 Jul; 55(7):1038-43. PubMed ID: 17608876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of the Medicare Part D coverage gap on medication use among patients with hypertension and hyperlipidemia.
    Li P; McElligott S; Bergquist H; Schwartz JS; Doshi JA
    Ann Intern Med; 2012 Jun; 156(11):776-84, W-263, W-264, W-265, W-266, W-267, W-268, W-269. PubMed ID: 22665815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.